Protocolo terapéutico del cáncer de vía biliar

  1. Cigarral, B. 1
  2. Fonseca, E. 1
  3. Vidal Tocino, R. 1
  4. Barrios, B. 1
  5. Casado, D. 1
  6. Claros, J. 1
  7. Escalera, E. 1
  8. Olivares, A. 1
  9. Figuero, L. 1
  10. Terán, E. 1
  11. López, A. 1
  12. Cruz, J.J. 1
  1. 1 Instituto de Investigación Biomédica de Salamanca (IBSAL), Servicio de Oncología Médica, Complejo Asistencial Universitario de Salamanca (CAUSA), Salamanca, España
Revista:
Medicine: Programa de Formación Médica Continuada Acreditado

ISSN: 0304-5412

Ano de publicación: 2021

Serie: 13

Número: 24

Páxinas: 1357-1359

Tipo: Artigo

DOI: 10.1016/J.MED.2021.01.006 DIALNET GOOGLE SCHOLAR

Outras publicacións en: Medicine: Programa de Formación Médica Continuada Acreditado

Resumo

Bile duct tumors are not frequent; they represent less than 1% of all tumors and are associated with a poor prognosis. They include gallbladder cancer and cholangiocarcinoma. Diagnosis is typically made in advanced stages and multimodal treatment that is individualized to each case is fundamental. Treatment consists of chemotherapy based on a combination of platinum and gemcitabine. Research on target molecular alterations is key for future therapeutic strategies and for improving the treatment and quality of life of these patients.

Referencias bibliográficas

  • Las cifras del cáncer en España 2020 – Sociedad Española de Oncología Médica.
  • Benavides M, Antón A, Gallego J, Gómez MA, Jiménez Gordo A, La Casta A, et al. Biliary tract cancers: SEOM clinical guidelines. Clin Transl Oncol. 2015;17(12):982-7.
  • Valle JW, Borbath I, Khan SA, Huguet F, Gruenberger T, Arnold D; ESMO Guidelines Committee. Biliary cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and followup. Ann Oncol. 2016;27Suppl5:v28-v37.
  • Sharma A, Dwary AD, Mohanti BK, Deo SV, Pal S, Sreenivas V, et al. Best supportive care compared with chemotherapy for unresectable gall bladder cancer: a randomized controlled study. J Clin Oncol. 2010;28(30):4581-6.
  • Benson AB, D’Angelica MI, Abbott DE, Abrams TA, Anaya DA, Anders R et al. Hepatobiliary cancers. Version 5.2020. NCCN Guidelines.
  • Stuart KE. Systemic therapy for advanced cholangiocarcinoma. UpToDate 2020. Disponible en: www.uptodate.com
Fonte de datos: Dialnet